Abstract Endothelial lipase (EL) is a major determinant of plasma HDL concentration, its activity being inversely proportional to HDL levels. Although it is known that it preferentially acts on HDL compared to LDL and VLDL, the basis for this specificity is not known. Here we tested the hypothesis that sphingomyelin, a major phospholipid in lipoproteins is a physiological inhibitor of EL, and that the preference of the enzyme for HDL may be due to low sphingomyelin/phosphatidylcholine (PtdCho) ratio in HDL, compared to other lipoproteins. Using recombinant human EL, we showed that sphingomyelin inhibits the hydrolysis of PtdCho in the liposomes in a concentration-dependent manner. While the enzyme showed lower hydrolysis of LDL PtdCho, compared to HDL PtdCho, this difference disappeared after the degradation of lipoprotein sphingomyelin by bacterial sphingomyelinase. Analysis of molecular species of PtdCho hydrolyzed by EL in the lipoproteins showed that the enzyme preferentially hydrolyzed PtdCho containing polyunsaturated fatty acids (PUFA) such as 22:6, 20:5, 20:4 at the sn-2 position, generating the corresponding PUFA-lyso PtdCho. This specificity for PUFA-PtdCho species was not observed after depletion of sphingomyelin by sphingomyelinase. These results show that sphingomyelin not only plays a role in regulating EL activity, but also influences its specificity towards PtdCho species.
Introduction
Endothelial lipase (EL, EC 3.1.1.3) is a unique member of the lipase family that functions more like a phospholipase than as a lipase [1] . It is expressed predominantly in the Electronic supplementary material The online version of this article (doi:10.1007/s11745-014-3944-1) contains supplementary material, which is available to authorized users. vascular endothelial cells, and to a lesser extent, in macrophages and smooth muscle cells, and preferentially hydrolyzes the phospholipids of HDL, compared to those of LDL and VLDL [1] . It is known to play an important role in the metabolism of HDL because the HDL levels are inversely correlated with the EL activity in plasma [2, 3] . HDL from EL-knockout mice stimulates greater efflux of cholesterol compared to normal HDL, although the overall reverse cholesterol transport is not increased [4] . The metabolism of apo B lipoproteins in vivo is also significantly affected by EL [5] . The basis for the preference of the enzyme for HDL is not clear, since unlike LCAT (EC 2.3.1.43) or lipoprotein lipase (EC 3.1.1.34), it does not require a specific apoprotein activator. Furthermore, because of its specificity for the sn-1 position of phosphatidylcholine (PtdCho), it produces predominantly unsaturated species of lyso PtdCho, in contrast to LCAT or secretory phospholipases, which produce mostly saturated species of lyso PtdCho. This property of EL may be physiologically important, since polyunsaturated fatty acids (PUFA) are transported more efficiently across the blood-brain barrier in the form of lyso PtdCho, than as corresponding free fatty acids [6] . The recent demonstration of a membrane transporter in endothelial cells of blood-brain barrier that specifically transports lyso PtdCho containing docosahexaenoic acid (DHA), but not free DHA [7] , further supports this mechanism Thus, EL may have an important role in supplying PUFA such as arachidonic acid and DHA to the brain, especially since it has been shown to be expressed and secreted by the endothelial cells of the brain capillaries [8] . Recent studies from our laboratory showed that EL preferably hydrolyzes the sn-2 DHA-PtdCho, producing DHA-lyso PtdCho [9] , lending additional support for this role.
While both the catalytic and non-catalytic (bridging) functions of EL appear to be involved in HDL clearance, the catalytic function is by far more important [10] . Enzymatic action of EL has also been shown to be critical for the HDL-induced angiogenesis [11] , and for the apo A1-mediated cholesterol efflux from the macrophages [12] . Therefore, identification of the factors that regulate the activity of EL would be important in understanding the regulation of HDL metabolism and function. Though the regulation of the expression of this enzyme has been well studied [5, [13] [14] [15] , very little is known about the physiological factors that regulate the activity of the enzyme in the plasma. It has been reported that the in vitro activity of the enzyme is inhibited by the addition of whole serum [1] , although the specific factors responsible for the inhibition have not been identified. The inhibition of EL by angiopoietin like protein 3 (ANG-PTL3) has been reported by Shimamura et al. [16] , apparently through binding to the heparin-binding region of the enzyme. Since EL does not require an apoprotein activator, its low activity towards VLDL and LDL compared to HDL suggests that a normal constituent of LDL and VLDL may play an inhibitory role. We have previously shown that sphingomyelin, the second most abundant phospholipid in the plasma lipoproteins, inhibits many of the phospholipases that use PtdCho as a substrate. These enzymes include LCAT [17] , and secretory phospholipases II, V, and X [18, 19] . The inhibition of lipoprotein lipase by sphingomyelin has also been reported [20, 21] . Since the sphingomyelin/PtdCho ratio in LDL and VLDL is much higher than that of HDL [17] , it is possible that one reason for the lower activity of EL on LDL and VLDL is the inhibition by sphingomyelin. The present studies were aimed at testing this hypothesis, and the results show that EL activity is indeed significantly inhibited by sphingomyelin in both artificial and lipoprotein substrates. The results also show that sphingomyelin affects the substrate specificity of EL towards the molecular species of PtdCho, leading to the generation of more polyunsaturated lyso PtdCho species as products.
Materials and Methods

Di-[
14 C] palmitoyl PtdCho (55 mCi/mmol) was purchased from American Radiochemicals, Inc. (St. Louis, MO, USA). Egg PtdCho, egg sphingomyelin, unlabeled dipalmitoyl PtdCho were purchased from Avanti Polar Lipids (Alabaster, AL, USA). Sphingomyelinase (EC 3.1.4.12) from B. cereus was obtained from Sigma-Aldrich (St. Louis, MO, USA).
Lipoproteins and EL
Pooled normal human plasma (never frozen) was obtained from a local blood bank, and VLDL, LDL, and HDL were prepared by sequential ultracentrifugation as described previously [17] . The lipoproteins were dialyzed extensively against 10 mM Tris-0.15 M NaCl-1 mM EDTA pH 7.4, and stored at 4°C. The phospholipid composition was analyzed by separation of the lipids by TLC, followed by determination of lipid phosphorus [22] . The lipoproteins were used for the enzyme reactions within 3 weeks of preparation. The expression of EL in COS cells transiently transfected with the adenovirus carrying human EL has been previously described [1] . In some studies, the enzyme expressed in FLP-IN 293 cells [12] was used. The conditioned medium was stored in aliquots at -80°C until use, and was thawed only once before use. Medium from control cells transfected with GFP-adenovirus was used as negative control in all experiments.
Liposome and Emulsion Substrates
Defined substrates containing either labeled PtdCho alone or with egg sphingomyelin were prepared by sonication. Chloroform solutions of labeled PtdCho (2 9 10 6 dpm of di-[ 14 C] palmitoyl PtdCho), 2.5 lmol of egg PtdCho or unlabeled dipalmitoyl PtdCho, and varying amounts of egg sphingomyelin were first dried under nitrogen, re-dissolved in 0.5 ml ethanol, and dried under nitrogen again. The lipids were then dispersed in 2 ml of 10 mM Tris-0.15 NaCl pH 7.4 by vortexing, and incubated at 37°C for 30 min. The sample was then sonicated with a microtip for 1 min at 4°C in a Sonics Vibro cell sonicator (Newton, CT, USA) at 40 % full power. In some experiments the liposomes were prepared by extrusion through 0.1 l filters at 40°C (Mini-Extruder, Avanti Polar Lipids). The enzyme activity with the liposomes prepared by the two methods was comparable (results not shown).
To prepare glycerol-stabilized emulsions, 2.0 lmol of labeled dipalmitoyl PtdCho (with or without 1.0 lmol egg sphingomyelin) was mixed with 18 lmol of cholesteryl oleate, and after evaporation of the solvent thoroughly, dispersed in 1 ml glycerol. The dispersion was sonicated for 2 min at room temperature, followed by 2 min in an ice bath, and finally at room temperature for 1 min. The emulsion was stored at 4°C, and was used within 1 week.
Labeling of Lipoproteins
VLDL, LDL, and HDL freshly isolated from pooled human plasma were labeled with di-[ 
EL Assays
The incubation mixture for the enzyme assay with the liposome substrate contained 350 nmol of PtdCho, varying amounts of egg sphingomyelin to give the indicated sphingomyelin:PtdCho ratios, 200 ll of EL-conditioned medium (about 350 lg protein), and 10 mM Tris-HCl buffer pH 7.4 containing 0.15 M NaCl in a final volume of 0.4 ml. Control samples contained the conditioned medium from GFP control cells. The incubation was carried out for 2-4 h at 37°C and was stopped by the addition of 1 ml methanol. The lipids were extracted by the Bligh and Dyer procedure [23] , and separated on a silica gel TLC plate with the solvent system of chloroform/methanol/water (65:25:4 by vol). The lipids were visualized by exposure to iodine vapors, and the spots corresponding to the standards of egg PtdCho, egg lyso PtdCho, and free fatty (oleic) acid were scraped, and their radioactivity determined in a liquid scintillation counter. In some experiments, the samples were acidified with HCl (to 0.1 N final) before lipid extraction, in order to ensure complete extraction of free fatty acids. The enzyme activity was expressed as % of PtdCho hydrolyzed or the products formed, after correcting for the GFP control values.
In the case of emulsion substrates, the reaction mixture contained 150 ll of glycerol-stabilized emulsion (containing 300 nmol of [ 14 C]-dipalmitoyl PtdCho and 150 nmol of sphingomyelin where indicated), 3 mg of BSA, 10 mM Tris buffer containing 0.15 M NaCl, and 200 ll of conditioned medium (EL) containing 350 lg total protein in a final volume of 0.4 ml. The incubation was performed for 2 h at 37°C, the reaction was stopped by the addition of 1 ml methanol, and the percent of PtdCho hydrolyzed was determined as described above.
Sphingomyelinase Treatment of Lipoproteins VLDL, LDL, or HDL (100 lg protein) was incubated with 0.05 units of sphingomyelinase from B. cereus (Sigma) for 1 h in 100 mM Tris buffer, pH 7.4. Then the EL-conditioned medium was added and the incubation continued for the indicated periods of time. LC/MS analysis of samples after sphingomyelinase treatment showed complete degradation of sphingomyelin in all the lipoproteins (Supplemental Fig. S1 ).
LC/MS Analysis
The analysis of lipids was carried out using an AB Sciex QTRAP 5500 mass spectrometer coupled to an Agilent 1260 HPLC system. The total lipid extract was mixed with internal standards (50 ng each) of 17:0-17:0 PtdCho, 17:0 lysoPtdCho, and 12:0 sphingomyelin, and was separated on a normal phase column (Supelco Ascentis Si 3l, 10 cm x 2.1 mm). The solvent system used was: 100 % solvent A (chloroform/methanol/2 mM aqueous ammonium chloride, 80:19.5:0.5 by vol.) from 0 to 5 min; then a linear gradient of 100 % solvent A to 100 % solvent B (chloroform/methanol/water/2 mM aqueous ammonium chloride, 60:34.5:5:0.5; by vol.) from 5 to 30 min; and 100 % solvent B from 30 to 35 min. The flow rate was 0.35 ml min were controlled using the Analyst 1.5 software (Applied Biosystems, Foster City, CA, USA).
Results
Effect of Sphingomyelin in Synthetic Substrates
We first determined the effect of sphingomyelin on the hydrolysis of PtdCho in liposome substrates containing egg PtdCho and increasing amounts of egg sphingomyelin. A trace amount of dipalmitoyl [ 14 C] PtdCho was included in the substrate to measure the enzyme activity. The activity was determined from the loss of radioactivity in PtdCho, as well as from the appearance of radioactivity in lyso PtdCho and FFA. As shown in Fig. 1a , there was a concentrationdependent inhibition of EL activity by sphingomyelin, with about 35 % inhibition when the ratio of sphingomyelin/ PtdCho was 0.25, and 50 % inhibition when the ratio was 0.5. The sphingomyelin/PtdCho ratios in normal human lipoproteins range from 0.15 to 0.45 [17] ; therefore, sphingomyelin inhibits the EL activity at physiological concentrations. In Fig. 1b , the effect of sphingomyelin was showing that sphingomyelin inhibition is not dependent upon the physical properties of the substrate. Although the labeled substrate used here (diplamitoyl -14 C PtdCho) had equal amounts of label in the sn-1 and sn-2 positions, the label appearing in FFA exceeded that in lyso PtdCho in most cases (results not shown), apparently due to the lysophospholipase activity of EL reported previously [24] .
EL Activity on Lipoproteins
To test the effect of sphingomyelin on EL activity in the native lipoproteins, we first labeled VLDL, LDL, and HDL (isolated from normal human plasma) with trace amounts of 14 C-dipalmitoyl PtdCho, and then treated them either directly with EL, or first with sphingomyelinase C for 1 h, followed by EL. The hydrolysis of the labeled PtdCho was determined from the loss of radioactivity in PtdCho as well as by the increase in the radioactivity in lyso PtdCho and free fatty acid spots after TLC separation. In addition, since sphingomyelinase is known to exhibit lysophospholipase activity [24] , we have also measured the radioactivity in the monoglyceride spot. As shown in Fig. 2 , EL hydrolyzed the labeled PtdCho in HDL more efficiently than in LDL or VLDL. Pre-treatment of the lipoproteins with sphingomyelinase, however, activated the PtdCho hydrolysis significantly in VLDL and LDL, but less so in HDL. This shows that the higher concentrations of sphingomyelin in VLDL and LDL may be responsible for the lower EL activity against these lipoproteins, compared to HDL. LC/ MS analysis of lipids showed that almost all sphingomyelin was degraded by sphingomyelinase in the lipoproteins under the conditions employed (Supplement, Fig. S1 ). The results in Fig. 2 were calculated from the loss of radioactivity in PtdCho. We have also determined the distribution of radioactivity in the two products, namely lyso PtdCho and FFA. Since the PtdCho was labeled equally between sn-1 and sn-2 positions, the radioactivity in lyso PtdCho and FFA should be equal if there is no further hydrolysis of lyso PtdCho by the enzyme. On the other hand, the counts on FFA will exceed that of lyso PtdCho if the enzyme shows lysophospholipase activity, as suggested by earlier studies [24] . Furthermore, since sphingomyelinase has been shown to hydrolyze the phosphodiester bond of lyso PtdCho [25] , the radioactivity in the neutral lipids (mainly monoglyceride) was also measured. As shown in Fig. 3 , in HDL and LDL not pre-treated with sphingomyelinase, the radioactivity in lyso PtdCho actually exceeded that of FFA and neutral lipids, indicating that no hydrolysis of lyso PtdCho has occurred. The lower amount of radioactivity in FFA is apparently due to an incomplete extraction of FFA, although the samples were acidified before extraction. In samples treated with sphingomyelinase, however, the radioactivity in FFA and neutral lipids exceeded that of lyso PtdCho, suggesting hydrolysis of lyso PtdCho by EL, or sphingomyelinase, or both. The effect of sphingomyelinase on lyso PtdCho hydrolysis was most apparent in HDL, and least evident in LDL. Sphingomyelinase by itself (in the absence of EL) showed very little lysophospholipase activity, and this baseline activity was subtracted from the total activity in the above calculations. These results suggest that the lyso PtdCho generated by the EL is further hydrolyzed by both EL and sphingomyelinase. Another possibility is that the lysophospholipase activity of EL also is inhibited by sphingomyelin, and that the degradation of sphingomyelin by sphingomyelinase released this inhibition.
Hydrolysis of Lipoprotein PtdCho: LC/MS Analysis
The data in Figs. 2 and 3 represent the hydrolysis of labeled 16:0-16:0 PtdCho incorporated into the lipoproteins. While this measures the overall activity of the enzyme on each lipoprotein, it may not accurately reflect the hydrolysis of endogenous PtdCho or the effect of sphingomyelin on this hydrolysis. Since the lipoproteins contain several different molecular species of PtdCho in varying percentages, it is also necessary to determine the specificity of EL toward the molecular species of PtdCho, and whether the specificity is influenced by sphingomyelin. Therefore, we analyzed the PtdCho composition of the lipoproteins by LC/MS before and after treatment with EL alone or with sphingomyelinase followed by EL. Figure 4 shows the decrease in PtdCho mass following incubation of each lipoprotein with EL before and after sphingomyelin depletion by sphingomyelinase. The percent hydrolysis of total PtdCho was greater in HDL than in LDL or VLDL before the depletion of sphingomyelin, although these differences were less striking than those observed with the PtdCho-labeled lipoproteins (Fig. 2) . Following sphingomyelin depletion, the PtdCho hydrolysis was stimulated significantly in all cases, and the differences between the lipoproteins disappeared, indicating that the concentration of sphingomyelin in the lipoprotein is an important physiological modulator of EL activity.
Substrate Specificity Towards Molecular Species of PtdCho
Although EL is known to be specific for the sn-1 position of lipoprotein PtdCho, the substrate preference for various molecular species present in native lipoproteins is not established. The studies of Duong et al. [26] , who compared recombinant HDLs containing single PtdCho species, showed that the catalytic efficiency of the enzyme for Since the native lipoproteins contain unequal amounts of different PtdCho species, and since other components of the lipoproteins (including sphingomyelin and apoproteins) could affect the specificity, we determined the PtdCho species hydrolyzed in native VLDL, LDL, and HDL before and after sphingomyelin depletion.
All the major PtdCho species in the lipoproteins were hydrolyzed by EL, quantitatively the most predominant being 16:0-18:2, 16:0-20:4, 18:0-18:2, and 18:0-20:4 species (Supplement Fig. S2 ). Since the PtdCho species are present in widely varying concentrations in the lipoproteins, the true specificity of the enzyme cannot be assessed by the decrease in absolute amount of each PtdCho species. To get a more accurate measure of the specificity, we calculated the contribution of individual PtdCho species to the total decrease (in percentage) and divided it by its initial concentration (percent of total PtdCho) in the lipoprotein. By this measure, a value above 1.0 indicates a relative preference of the enzyme for the given PtdCho species compared to the 'average' PtdCho, while a value lower than 1.0 indicates that it is less preferred than 'average' PtdCho. By this criterion, the enzyme preferentially hydrolyzed PtdChos containing polyunsaturated fatty acids (20:4, 20:5, 22:5, 22:6) at sn-2 in the native VLDL and LDL (Fig. 5) . Treatment with sphingomyelinase, however, virtually eliminated this preference in VLDL, indicating a possible effect of sphingomyelin in determining the specificity of the enzyme. Similarly, treatment of LDL with sphingomyelinase decreased the EL specificity for most of the unsaturated PtdChos. In native HDL, only PtdCho species containing 22:6 and 20:5 in the sn-2 position showed a slight preferential hydrolysis by EL. Pre-treatment with sphingomyelinase eliminated this preference, as found for VLDL and LDL. These results suggest that in the native lipoproteins, the polyunsaturated PtdCho species are the preferred substrates for EL, and that this specificity is at least in part due to the presence of sphingomyelin, since the depletion of sphingomyelin virtually eliminated the differences between PtdCho species. Changes in Lyso PtdCho Species Figure 6 shows the lyso PtdCho species formed by the action of EL in the presence and absence of added sphingomyelinase. The major lyso PtdCho formed was 18:2 lyso PtdCho in all lipoproteins, followed by 20:4, 20:3, and 18:1. These results agree with the decrease in the PtdCho species containing the corresponding fatty acids in the sn-2 position (Supplement Fig. S2 ), and also confirm the specificity of the enzyme for the sn-1 position of PtdCho. The omega-3 polyunsaturated lyso PtdChos (22:6 and 20:5) were minor products of the enzyme reaction because of the low concentrations of the corresponding PtdCho species in all lipoproteins, although EL shows preference for these species of PtdCho. An interesting observation is that the saturated lyso PtdChos (16:0 and 18:0), which are the predominant lyso PtdChos in the native lipoproteins, actually decreased in concentration after treatment with a combination of EL and sphingomyelinase, but not in the presence of EL alone. These results suggest that lyso PtdCho is either hydrolyzed by sphingomyelinase C alone, or by EL alone after the depletion of sphingomyelin, or by a combination of the two activities. It should be pointed out that the lyso PtdCho values shown are corrected for the controls containing only sphingomyelinase C (no EL), and therefore, it appears that EL hydrolyzed the lyso PtdCho, but only after the depletion of sphingomyelin by sphingomyelinase C.
Discussion
Although sphingomyelin is one of the major phospholipids in human plasma, comprising up to 30 % of the total phospholipids in some lipoproteins [27, 28] , its physiological role in the lipoproteins is not clearly known. Several reports suggested that sphingomyelin is an independent risk factor for atherosclerosis [29] [30] [31] , although a more recent multi-center, multi-ethnic study showed that high plasma sphingomyelin is actually associated with a modest reduction in coronary heart disease [32] . Previous studies from our laboratory and from others have shown that one important function of sphingomyelin is the inhibition of hydrolysis of lipoprotein PtdCho by LCAT [17, [33] [34] [35] and various secretory phospholipases [18, 19, 36] , thereby preventing uncontrolled degradation of this important structural component. The results presented here show that sphingomyelin may also be involved in regulating the activity of EL, which is an important determinant of HDL concentration in human plasma. In addition, these results provide a possible explanation for the low activity of EL on LDL and VLDL, compared to HDL, because LDL and VLDL have higher sphingomyelin/PtdCho ratios than HDL [17] . It is of interest to note that EL activity is increased during inflammatory conditions [37] . This increase in EL activity could be partly due to the increased presence of secretory sphingomyelinase during inflammation [38] , and the consequent degradation of sphingomyelin in the lipoproteins, which in turn activates the EL activity.
The results presented here also show that EL preferentially hydrolyzes PtdCho species containing the polyunsaturated acyl groups (22:6, 20:5, 20:4) at the sn-2 position, generating the corresponding polyunsaturated lyso PtdCho species because of its specificity for the sn-1 position. This specificity appears to be abolished after depletion of sphingomyelin, suggesting a possible role for sphingomyelin in not only regulating the activity of the enzyme, but also its substrate specificity. It is possible that sphingomyelin associates with the less unsaturated PtdCho species such as 16:0-18:1 and 16:0-18:2, and thus specifically inhibits their hydrolysis, but does not affect the hydrolysis of the polyunsaturated species such as 16:0-22:6 PtdCho. The weak interaction of sphingomyelin with the polyunsaturated PtdCho species as reported in the model membranes [39] supports this possibility. The generation of polyunsaturated lyso PtdCho in the plasma may be physiologically significant, since the brain has been shown to take up the long chain polyunsaturated fatty acids such as 20:4 and 22:6 in the form of lyso PtdCho up to 12 times more efficiently than the corresponding free fatty acids [40] . The presence of a specific transporter in the bloodbrain barrier that preferentially transports the lyso PtdCho form of DHA [7] further supports this possibility. It would be of interest to determine whether the levels of 20:4 and 22:6 in the brain are decreased in EL knockout mice, since these mice would be expected to have a defect in generating polyunsaturated lyso PtdChos.
